Prosecution Insights
Last updated: July 17, 2026
Application No. 19/208,072

SYSTEM AND METHOD FOR IMPLEMENTING EMPLOYER HEALTH CARE COST SAVINGS

Non-Final OA §101
Filed
May 14, 2025
Priority
Mar 18, 2019 — provisional 62/819,947 +4 more
Examiner
YU, ARIEL J
Art Unit
Tech Center
Assignee
Care Coordination Systems LLC
OA Round
1 (Non-Final)
40%
Grant Probability
Moderate
1-2
OA Rounds
3y 0m
Est. Remaining
68%
With Interview

Examiner Intelligence

Grants 40% of resolved cases
40%
Career Allowance Rate
159 granted / 394 resolved
-19.6% vs TC avg
Strong +27% interview lift
Without
With
+27.3%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
40 currently pending
Career history
435
Total Applications
across all art units

Statute-Specific Performance

§101
4.3%
-35.7% vs TC avg
§103
88.5%
+48.5% vs TC avg
§102
5.0%
-35.0% vs TC avg
§112
0.7%
-39.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 394 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Drawings The drawings filed on 06/13/2025 are accepted by the examiner. Double Patenting A rejection based on double patenting of the “same invention” type finds its support in the language of 35 U.S.C. 101 which states that “whoever invents or discovers any new and useful process... may obtain a patent therefor...” (Emphasis added). Thus, the term “same invention,” in this context, means an invention drawn to identical subject matter. See Miller v. Eagle Mfg. Co., 151 U.S. 186 (1894); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Ockert, 245 F.2d 467, 114 USPQ 330 (CCPA 1957). A statutory type (35 U.S.C. 101) double patenting rejection can be overcome by canceling or amending the claims that are directed to the same invention so they are no longer coextensive in scope. The filing of a terminal disclaimer cannot overcome a double patenting rejection based upon 35 U.S.C. 101. Claims 1-20 are provisionally rejected under 35 U.S.C. 101 as claiming the same invention as that of claims 1-20 of copending Application No. 19/197464 (reference application). This is a provisional statutory double patenting rejection since the claims directed to the same invention have not in fact been patented. At least one employer is a beneficiary of this CCN (specification, paragraph 267). Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-20 are rejected under 35 USC 101. The claimed invention is directed to non-statutory subject matter because claims 1, 11, and 20 are directed to an abstract idea without significantly more. Claims 2-10 and 12-19 fail to remedy these deficiencies. The claims 1, 11, and 20 recite collecting client health and financial data, analyzing data collected, extracting analyzed data and applying it to an least one condition in a set of pre-set conditions, calculating an initiative cost per client, training at least one AI model using information, predicting the ROI and the timing of a given care plan, establishing care plan priorities to achieve objectives, routing to appropriate care network partners, developing key performance indicators and milestones per client, displaying data for user to self-evaluate performance, implementing the care plan, sending money from an AMF to a money management organization, sending money saved to the money management organization for redistribution, and redistributing the money to one or more employers. Claims 1, 11, and 20 recite analyzing, extracting, applying, calculating, training, predicting, establishing, routing, developing, displaying, implementing, sending. And redistributing steps as drafted, are processes that under broadest reasonable interpretation, cover performance of managing commercial interactions and fundamental economic practices, but for the recitation of generic computer components. That is, other than reciting “a hub computing device which operates as a hub portal comprising a processor, a display and a non-transitory computer-readable storage medium, a data collection component, an artificial intelligence engine, comprising non-transitory computer-readable storage medium, external client databases, a CCN component comprising non-transitory computer-readable storage medium, and a CCS health system”, nothing in the claim element precludes the steps from practically being performed by organizing human activity for commercial interactions and fundamental economic practices. For example, but for “the hub computing device/the hub portal, the processor, the display, the non-transitory computer-readable storage medium, the data collection component, the artificial intelligence engine, the external client databases, the CCN component, and the CCS health system” in the context of these claims encompasses a person manually analyzes client health and financial data, extracts the analyzed data and applies it to an least one condition, calculates an initiative cost per client, trains the at least one AI model using client information, predicts the ROI and the timing of a given care plan, establishes care plan priorities to achieve objectives, routes/directs to appropriate care network partners, develops key performance indicators and milestones per client, displays data for user to self-evaluate performance, implements the care plan to increase efficiency and save money, sends the saved money to a money management organization for redistribution, and redistributes the money to one or more employers. If a claim limitation, under its broadest reasonable interpretation, covers performance of the limitation by managing commercial interactions and fundamental economic practices but for the recitation of generic computer components, then it falls within the “Certain Methods of Organizing Human Activity” grouping of abstract ideas. Accordingly, the claims recite an abstract idea. This judicial exception is not integrated into a practical application because collecting step is recited at a high level of generality (i.e., as a general means of collecting client health and financial data) and amounts to mere data gathering, which is a form of insignificant extra-solution activity. This judicial exception is not integrated into a practical application because the claims as a whole merely describe how to generally “apply” the concept of collecting, analyzing, extracting, applying, calculating, training, predicting, establishing, routing, developing, displaying, implementing, sending. And redistributing in a computer environment. The claimed computer components such as the hub computing device/the hub portal, the processor, the display, the non-transitory computer-readable storage medium, the data collection component, the artificial intelligence engine, the external client databases, the CCN component, and the CCS health system are recited at a high level of generality and are merely invoked as tools to perform collecting, analyzing, extracting, applying, calculating, training, predicting, establishing, routing, developing, displaying, implementing, sending. And redistributing steps. Simply implementing the abstract idea on a generic computer is not a practical application of the abstract idea. Accordingly, this additional element does not integrate the abstract idea into a practical application because it does not impose any meaningful limits on practicing the abstract idea. The claims 1, 11 and 20 are directed to an abstract idea. The claims 1, 11, and 20 do not include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed above with respect to integration of the abstract idea into a practical application, the additional elements of using the hub computing device/the hub portal, the processor, the display, the non-transitory computer-readable storage medium, the data collection component, the artificial intelligence engine, the external client databases, the CCN component, and the CCS health system to perform collecting, analyzing, extracting, applying, calculating, training, predicting, establishing, routing, developing, displaying, implementing, sending. And redistributing steps amount to no more than mere instructions to apply the exception using generic computer components. Mere instructions to apply an exception using a generic computer component cannot provide an inventive concept. Therefore, the claims do not amount to significantly more than the recited abstract idea (Step 2B: NO). The claims 1, 11, and 20 are not patent eligible. Claims 2-10 and 12-20, disclose insignificant helpful content to further describe content, such as a neural network, different beneficiaries/employers of this CCN, different external client information, data evaluation during treatment based on changes, the care plan budget achievement determination, a new ROI and timing of a new care plan calculation, different types of hardware and software for the artificial engine, ransomware- proof/quantum-safe IT security to provide encryption to relevant data, and any leftover money is used for further investment, which are merely descriptive content to further limit the abstract idea but not make it less abstract. Thus, the claims 2-10 and 12-20 are directed to an abstract idea. This judicial exception is not integrated into a practical application because descriptive content in claims 2-10 and 12-20 further limit the abstract idea but not make it less abstract. Thus, the claims 2-10 and 12-20 are directed to an abstract idea. There are no additional claim element limitations recited in the claims 2-10 and 12-20. Therefore, the claim does not amount to significantly more than the recited abstract idea (Step 2B: NO). The claims 2-10 and 12-20 are not patent eligible. Conclusion Please refer to form 892 for cited references. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ARIEL J YU whose telephone number is (571)270-3312. The examiner can normally be reached 11AM - 7PM (M-F). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Obeid Fahd A can be reached on 571-270-3324. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ARIEL J YU/Primary Examiner, Art Unit 3627
Read full office action

Prosecution Timeline

May 14, 2025
Application Filed
Jul 02, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12682411
NETWORK DETECTION-BASED MONITORING OF ELECTRONIC MERCHANDISE
6y 2m to grant Granted Jul 14, 2026
Patent 12670773
TRUST-BASED BAG CHECKS IN A RETAIL ENVIRONMENT
3y 2m to grant Granted Jun 30, 2026
Patent 12664571
VALIDATING IDENTIFICATION OF A USER FOR PURCHASE OF AGE-RESTRICTED ITEMS
2y 3m to grant Granted Jun 23, 2026
Patent 12579524
CRYPTOCURRENCY TERMINAL AND TRANSACTION PROCESSING
8y 1m to grant Granted Mar 17, 2026
Patent 12579526
TARGETED REMOTE PAYMENTS LEVERAGING ULTRA-WIDEBAND (UWB) AND MICRO-ELECTROMECHANICAL SYSTEMS (MEMS) SENSOR COMMUNICATIONS
2y 11m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
40%
Grant Probability
68%
With Interview (+27.3%)
4y 2m (~3y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 394 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month